<DOC>
	<DOCNO>NCT00955942</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-ray kill tumor cell . Flaxseed may help protect normal cell side effect radiation therapy . PURPOSE : This randomized phase I trial study side effect flaxseed supplement treat patient locally advanced metastatic non-small cell lung cancer undergo chemotherapy radiation therapy .</brief_summary>
	<brief_title>Flaxseed Supplement Treating Patients With Locally Advanced Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy Radiation Therapy</brief_title>
	<detailed_description>OBJECTIVES : Primary - To assess feasibility dietary flaxseed ( FS ) supplementation patient undergo definitive chemoradiotherapy locally advance metastatic non-small cell lung cancer . - To collect toxicity tolerability data dietary FS supplementation definitive chemoradiotherapy . Secondary - To validate urinary serum marker oxidative stress FS lignan level surrogates bioavailability FS patient . - To determine dose response daily ingestion 20 g 40 g FS observe plasma lignan level urinary marker oxidative stress . OUTLINE : Patients randomize 1 2 treatment arm . - Arm I : Patients consume flaxseed muffin twice daily begin first day radiotherapy continue 9-10 week . - Arm II : Patients consume placebo muffin twice daily begin first day radiotherapy continue 9-10 week . Blood urine sample collect periodically biomarker study . After completion study treatment , patient follow 1 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis nonsmall cell lung cancer Locally advance metastatic disease Requires definitive thoracic mediastinal radiotherapy concurrent chemotherapy Total plan radiation dose gross disease 6080 Gy PATIENT CHARACTERISTICS : No diagnosis disease gastrointestinal ( GI ) system , liver , kidney could result altered metabolism excretion study medication ( e.g. , history major GI tract surgery , gastrectomy , gastrostomy , bowel resection ) No history chronic GI disorder ( e.g. , ulcerative colitis , regional enteritis , GI bleed ) No know hypersensitivity flaxseed metabolites wheat product PRIOR CONCURRENT THERAPY : See Disease Characteristics See Patient Characteristics More 14 day since prior concurrent investigational drug More 14 day since prior concurrent amifostine Mucomyst ( Nacetylcysteine ) No prior thoracic radiotherapy No prior concurrent flaxseed , flaxcontaining product , soybean , soycontaining product No concurrent dietary supplement , herbal botanical Vitamins multivitamin , include calcium vitamin D , allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>radiation toxicity</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
</DOC>